Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC vs FAC in Node-Positive Breast Cancer
NCT00688740Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 1997
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Sanofi. Started Jun 1997; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00688740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688740.